Výsledky vyhledávání - "Timothy Volmer"

Ocrevus reduces TH40 cells, a biomarker of systemic inflammation, in relapsing multiple sclerosis (RMS) and in progressive multiple sclerosis (PMS)

Autor: Christian Curran, Gisela Vaitaitis, Dan Waid, Timothy Volmer, Enrique Alverez, David H. Wagner

Publikováno v: Journal of Neuroimmunology. 374:578008

Treating MS has been difficult. One successful drug is Ocrelizumab (anti-CD20), used for the chronic relapsing MS (RMS) and the progressive MS (PMS) forms. TH40 cells are pathogenic effector T cells that increase in percentage and numbers during chro

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c16cd634d3ebd7e0ee1152a67d282e2f
https://doi.org/10.1016/j.jneuroim.2022.578008

Zobrazit plný text záznamu

Akademický článek

Acknowledgement.

Publikováno v: Journal of Autism & Developmental Disorders. Dec2002, Vol. 32 Issue 6, p617. 3p.

Zobrazit plný text záznamu

Periodical

Investigators at University of Colorado Describe Findings in Multiple Sclerosis [Ocrevus Reduces Th40 Cells, a Biomarker of Systemic Inflammation, In Relapsing Multiple Sclerosis (Rms) and In Progressive Multiple Sclerosis (Pms)].

Publikováno v: Immunotherapy Weekly; 1/31/2023, p638-638, 1p

Zobrazit plný text záznamu

Akademický článek

Models of Care in Multiple Sclerosis September 27-29, 1996 Atlanta, Georgia, USA.

Publikováno v: Multiple Sclerosis (13524585); Sep1996, Vol. 2 Issue 2, p96-119, 24p

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání